1. Sanofi (28 from 1,451 patents)

2. Sanofi-synthelabo (9 from 152 patents)

3. Elf Sanofi (4 from 53 patents)

4. Sanofi-aventis (3 from 389 patents)

5. Other (1 from 832,680 patents)

6. Societe Anonyme: Elf Sanofi (1 from 2 patents)

1. 7521449 - 4-arylmorpholin-3-one derivatives, their preparation and therapeutic use thereof

2. 7390823 - Use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of all mood disorders, adaptation disorders or mixed anxiety-depression disorders

3. 6951940 - Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them

4. 6642233 - 1-Phenacyl-3-phenyl-3-(piperidylethyl)piperidine derivatives, process for the preparation thereof and pharmaceutical compositions containing them

5. 6573281 - Use of saredutant for the treatment of adaptation, bipolar, and dysthymic disorders

6. 6506750 - Morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives

7. 6465489 - Ureidopiperidine derivatives as selective human NK3 receptor antagonists

8. 6420388 - Osanetant in the treatment of depression and depressive disorders

9. 6294537 - Compounds which are specific antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools

10. 6291672 - Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them

11. 6242637 - Substituted heterocylic compounds, method of preparing them and pharmaceutical compositions in which they are present

12. 6124316 - Compounds which are specific antagonists of the human NK3 receptor and

13. 6028082 - Human NK.sub.3 receptor-selective antagonist compounds, method for

14. 6011154 - Substituted heterocyclic compounds, method of preparing them and

15. 5977359 - Substituted heterocyclic compounds, method of preparing them and